Announcement

Huma and Pfizer collaborate to launch the Huma Cloud Platform for Hemophilia

January 20, 2025
Announcement

Huma and Pfizer collaborate to launch the Huma Cloud Platform for Hemophilia

January 20, 2025

This is some text inside of a div block.
mins read
Speaker shot.

Speaker shot.

Speaker shot.

Transforming care and engagement for individuals living with Hemophilia through advanced Remote Patient Monitoring technology.‍

‍

‍Jan 14, 2025 - New York - Huma today announced a strategic collaboration with Pfizer Inc. (NYSE: PFE) to introduce the Huma Cloud Platform for Hemophilia in the United States. This partnership leverages Huma’s FDA Class 2 510k cleared Remote Patient Monitoring (RPM) solution to provide personalized, data-driven support that enhances patient engagement, adherence to therapy, and communication with healthcare providers—empowering individuals living with Hemophilia and their caregivers.

‍

‍Bridging gaps in Hemophilia care‍

Hemophilia patients often face challenges managing complex treatment regimens and accessing specialized care. Huma’s cutting-edge RPM platform, built on the Huma Cloud Platform, delivers a secure, user-friendly experience, combining a patient-focused mobile app with a clinician-facing portal for real-time remote monitoring. Key features include:‍

  • Health tracking: Log bleeds, track symptoms, vital signs, and treatment adherence.‍
  • Personalized support: Tailored patient education and oversight through nurse navigators.‍
  • Enhanced connectivity: Streamlined communication between patients and providers.

The regulatory framework of the platform also lays the groundwork for integrating AI-powered algorithms and clinical decision support tools in the future, driving proactive and efficient care delivery.

‍

‍Driving digital innovation

The Huma Cloud Platform offers Pfizer and other partners a scalable, no-code, cloud-agnostic framework to rapidly develop and deploy regulated digital solutions for patients with the ability add-on relevant services with ease. By enabling swift, compliant customization across therapeutic areas, it accelerates access to innovative, patient-centric care.

“We are proud to partner with Pfizer to deliver transformative solutions for Hemophilia care,” said Dan Vahdat, CEO and Founder of Huma. “The Huma Cloud Platform reflects our shared vision to empower patients through technology, improving engagement, adherence, and ultimately health outcomes.”

‍

About Huma‍

Huma is a global healthcare AI company accelerating the adoption of digital solutions for care and research. Huma’s cloud-based platform, trusted by over 4,500 hospitals and clinics globally, is FDA Class II and EU MDR Class IIb cleared, enabling rapid, customizable, and compliant solutions that transform patient outcomes.

‍

‍Huma media contact

Courtney Obecny

VP of Marketing

Courtney.Obecny@huma.com 

401-573-5438

‍

This field is required
Email must be formatted correctly
This field is required
This field is required
This field is required

Huma is committed to respecting your privacy, we’ll always treat your personal details with the utmost care and will never sell them to other companies for marketing purposes. You can unsubscribe at any time. Review our Privacy Policy for further information.

Keep up to date on our current work and research with the latest marketing updates from Huma, including monthly news, events and communications on products and services.

By clicking submit below, you consent to allow Huma to store and process the personal information submitted above to provide you the content requested.

One of our team members will be in touch with you shortly.
Oops! Something went wrong while submitting the form.
Join the waitlist

This field is required
This field is required
This field is required
This field is required
Thank you for your request.
You will receive an email from us shortly containing the file. Please check your inbox (and promotions tab or spam folder, if necessary) for the email.
Oops! Something went wrong while submitting the form

Email must be formatted correctly
This field is required
This field is required
This field is required
This field is required
This field is required
Country/Region*
This field is required
I'm interested in

Huma is committed to respecting your privacy, and we’ll only use your personal details to provide information you have selected you’re interested in. Review our Privacy Policy for further information.

We’d love to send you our monthly newsletter about our latest work, research and events by email. We’ll always treat your personal details with the utmost care and will never sell them to other companies for marketing purposes.

You’re in control. You can, of course, withdraw your consent at any time. Review our Privacy Policy for further information.

One of our team members will be in touch with you shortly.
Oops! Something went wrong while submitting the form.

Making an impact

3000+

3000+ hospitals and clinics supported across Huma platforms to secure the most sustainable impact for patients1

×2

Our platform can almost double clinical capacity and reduce readmission rates by >30%3

27m+

Huma's digital-first health platforms support a network of 27m patients1

1m+

Over 1 million devices have been shipped in support of our projects and we know what it takes to deploy at scale1

Winner of the 2022 Prix Galien award for digital health, widely regarded as 'pharma's Nobel prize'4

Selected as one of 'The Most Important Healthcare Design of 2021' by Fast Company5

Winner of the 2022 Prix Galien award for digital health, widely regarded as 'pharma's Nobel prize'4

Winner of the 2022 Prix Galien award for digital health, widely regarded as 'pharma's Nobel prize'4

About Huma

Sources:

Announcement

Huma and Pfizer collaborate to launch the Huma Cloud Platform for Hemophilia

January 20, 2025
Announcement

Huma and Pfizer collaborate to launch the Huma Cloud Platform for Hemophilia

January 20, 2025

Huma joins digital pioneers to advance health equity in care and research

Chief Executive Officer and Founder, Dan Vahdat, is returning to the annual World Economic Forum’s main conference where he will join a panel discussion devoted to improving care for non-communicable disease and tackling health equity. Accompanied by Chief Financial and Strategy Officer, Ingeborg Oie, Dan is looking forward to connecting with other attendees to explore how Huma’s digital health platform can make healthcare more equitable, and advances proactive, predictive care.
Book a meeting

Huma joins digital pioneers to advance health equity in care and research

Date:Wednesday, January 18, 2023
Time:4:15 - 5:15 p.m. CET
Location:Ice Village, Eisbahnstrasse 5, Davos, Switzerland
Dan will join the Digital Health Action Alliance panel at Davos to discuss Turning the Tide in Non-Communicable Disease Care Through Digital Health and Community Connection. Huma has a long history of advancing the care of non-communicable diseases (NCDs) such as heart disease, cancer, diabetes and lung conditions. Huma’s innovative remote patient monitoring platform enables broad patient recruitment, reduces reliance on in-person clinic visits and increases health system efficiency.
*This session is open to registered Annual Meeting 2023 participants and Affiliate badge holders.
Learn more

Huma is one of the first to sign the Zero Health Gaps Pledge

Huma is one of the first signatories to the Zero Health Gaps Pledge, the World Economic Forum’s Global Health Equity Network’s (GHEN) initiative. Huma supports GHEN’s ambition to build a future without disparities in health or wellbeing outcomes. Huma’s digital platform has been built on a deep clinical knowledge of complex patient needs and how people engage with technology and we are committed to ensuring our technology promotes health equity. We are proud to work with governments, hospital groups, universities, life science and technology companies to bring greater scale and impact and help all people live longer, fuller lives.
Find out more

Huma at World Economic Forum

Global Innovators and Tech Pioneers
Dec 2022: Huma selected to join 100 innovative companies on a two-year journey as part of the World Economic Forum’s initiatives, activities and events, bringing their cutting-edge insight and fresh thinking to critical global discussions.
Learn more
Working Together, Restoring Trust
May 2022: With the aim to address economic, environmental, political, and social fault-lines exacerbated by the COVID-19 pandemic, Dan Vahdat speaks at WEF annual meeting about the importance of scientific collaboration.
Learn more
Accelerating innovation and breaking new ground
October 2022: Dan joined the WEF Biotech Future Forum 2022 to discuss how start-ups are breaking new ground in biotech and changing the way we interact with the world, but also how the sector can earn trust, scale successfully and spot the brightest innovations.
Learn more
Making connections at Davos
Jan 2019: Dan attended WEF as an unofficial attendee and spoke to CNBC about the importance of meeting in-person to make connections.
Learn more
Announcement

Huma and Pfizer collaborate to launch the Huma Cloud Platform for Hemophilia

January 20, 2025
Media contact
Announcement

Huma and Pfizer collaborate to launch the Huma Cloud Platform for Hemophilia

January 20, 2025
Media contact

Transforming care and engagement for individuals living with Hemophilia through advanced Remote Patient Monitoring technology.‍

‍

‍Jan 14, 2025 - New York - Huma today announced a strategic collaboration with Pfizer Inc. (NYSE: PFE) to introduce the Huma Cloud Platform for Hemophilia in the United States. This partnership leverages Huma’s FDA Class 2 510k cleared Remote Patient Monitoring (RPM) solution to provide personalized, data-driven support that enhances patient engagement, adherence to therapy, and communication with healthcare providers—empowering individuals living with Hemophilia and their caregivers.

‍

‍Bridging gaps in Hemophilia care‍

Hemophilia patients often face challenges managing complex treatment regimens and accessing specialized care. Huma’s cutting-edge RPM platform, built on the Huma Cloud Platform, delivers a secure, user-friendly experience, combining a patient-focused mobile app with a clinician-facing portal for real-time remote monitoring. Key features include:‍

  • Health tracking: Log bleeds, track symptoms, vital signs, and treatment adherence.‍
  • Personalized support: Tailored patient education and oversight through nurse navigators.‍
  • Enhanced connectivity: Streamlined communication between patients and providers.

The regulatory framework of the platform also lays the groundwork for integrating AI-powered algorithms and clinical decision support tools in the future, driving proactive and efficient care delivery.

‍

‍Driving digital innovation

The Huma Cloud Platform offers Pfizer and other partners a scalable, no-code, cloud-agnostic framework to rapidly develop and deploy regulated digital solutions for patients with the ability add-on relevant services with ease. By enabling swift, compliant customization across therapeutic areas, it accelerates access to innovative, patient-centric care.

“We are proud to partner with Pfizer to deliver transformative solutions for Hemophilia care,” said Dan Vahdat, CEO and Founder of Huma. “The Huma Cloud Platform reflects our shared vision to empower patients through technology, improving engagement, adherence, and ultimately health outcomes.”

‍

About Huma‍

Huma is a global healthcare AI company accelerating the adoption of digital solutions for care and research. Huma’s cloud-based platform, trusted by over 4,500 hospitals and clinics globally, is FDA Class II and EU MDR Class IIb cleared, enabling rapid, customizable, and compliant solutions that transform patient outcomes.

‍

‍Huma media contact

Courtney Obecny

VP of Marketing

Courtney.Obecny@huma.com 

401-573-5438

‍

asdasd

asda

asdsads

asda

asdsad

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor
Download
Share this

Recent Press Releases

See more
Announcement
Huma and Wheel partner to deliver a Direct-to-Consumer Platform as a Service
January 15, 2025
Announcement
Samsung, Huma and Tulane University’s HEARTBEAT 10,000 Study Enrolls First Patient
December 13, 2024
COMPANY

About Huma

Huma began its journey in 2011, when the company was founded in London. Since then, Huma has grown to become a global healthcare company, spanning across multiple geographies and operating across four continents.

Learn more

London

Millbank Tower
21-24 Millbank
London SW1P 4QP
UK

New York

14 Penn Plaza
225 West 34th Street
Floor 9
New York NY 10122
USA